FB2026_02 , released June 18, 2026
Allele: Dmel\Met2
Open Close
General Information
Symbol
Dmel\Met2
Species
D. melanogaster
Name
FlyBase ID
FBal0045043
Feature type
allele
Associated gene
Associated Insertion(s)
Carried in Construct
Key Links
Genomic Maps

Allele class
Nature of the Allele
Allele class
Progenitor genotype
Cytology
Description

Amino acid replacement: Q401term.

Mutations Mapped to the Genome
Curation Data
Type
Location
Additional Notes
References
Nucleotide change:

C11618068T

Amino acid change:

Q401term | Met-PA; Q401term | Met-PB

Reported amino acid change:

Q401term

Comment:

Site of nucleotide substitution in mutant inferred by FlyBase based on reported amino acid change.

Variant Molecular Consequences
Associated Sequence Data
DNA sequence
Protein sequence
 
Expression Data
Reporter Expression
Additional Information
Statement
Reference
 
Marker for
Reflects expression of
Reporter construct used in assay
Human Disease Associations
Disease Ontology (DO) Annotations
Models Based on Experimental Evidence ( 0 )
Disease
Evidence
References
Modifiers Based on Experimental Evidence ( 0 )
Disease
Interaction
References
Comments on Models/Modifiers Based on Experimental Evidence ( 0 )
 
Disease-implicated variant(s)
 
Phenotypic Data
Phenotypic Class
Phenotype Manifest In
Detailed Description
Statement
Reference

Homozygotes show increased resistance to methoprene compared to controls.

Homozygous females have a reduced rate of oviposition compared to controls.

16% of mutant flies have a small number of defective ommatidia in the posterior quarter of the eye.

Flies carrying Rst(1)JH2 have a competitive disadvantage compared to wild-type flies.

Rst(1)JH1 mutants are 6 times more resistant than wild-type to S31183 (2-1-methyl-2-(4-phenoxyphenoxy)-ethoxy-pyridine), a juvenile hormone mimic, in a white puparial assay and about 20 times more resistant than wild-type to S31183 in a larval feeding assay.

Moderate allele. Only minor differences in penetration, excretion, sequestration and metabolism of juvenile hormone III are detected in Rst(1)JH2 flies compared to Rst(1)JH+ flies. Rst(1)JH2 flies have an approximately 5-fold lower binding affinity for juvenile hormone III than Rst(1)JH+ flies.

Homozygotes are resistant to methoprene, although less strong than Rst(1)JH1. Also resistant to methoprene induced morphogenetic abnormalities and tumours. Heterozygous males are susceptible to methoprene. Rst(1)JH1/Rst(1)JH2 transheterozygotes are more resistant to methoprene than Rst(1)JH2 homozygotes.

External Data
Interactions
Show genetic interaction network for Enhancers & Suppressors
Phenotypic Class
Phenotype Manifest In
Additional Comments
Genetic Interactions
Statement
Reference
Xenogenetic Interactions
Statement
Reference
Complementation and Rescue Data
Comments
Images (0)
Mutant
Wild-type
Stocks (0)
Notes on Origin
Discoverer
Comments
Comments

The fitness component(s) responsible for the competitive disadvantage of flies carrying mutant alleles of Rst(1)JH have been analysed in Rst(1)JH1, Rst(1)JH2, Rst(1)JH3, Rst(1)JHD29 and Rst(1)JHN6 flies. Small but significant differences were found between the pooled Rst(1)JH alleles and wild-type for pupal developmental time, pupal mortality, and early adult fecundity. These differences results in a large competitive disadvantage.

External Crossreferences and Linkouts ( 0 )
Synonyms and Secondary IDs (3)
Reported As
Name Synonyms
Secondary FlyBase IDs
    References (7)